Hanny Al-Samkari Selected Research

mitapivat

1/2022	Mitapivat versus Placebo for Pyruvate Kinase Deficiency. Reply.
1/2022	Mitapivat versus Placebo for Pyruvate Kinase Deficiency.
1/2021	Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hanny Al-Samkari Research Topics

Disease

27	Hemorrhage 08/2022 - 01/2018
24	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 10/2022 - 01/2018
18	Neoplasms (Cancer) 03/2022 - 01/2018
17	Thrombocytopenia (Thrombopenia) 10/2022 - 01/2018
12	Hereditary Hemorrhagic Telangiectasia 07/2022 - 01/2019
12	Thrombosis (Thrombus) 01/2022 - 01/2018
7	Anemia 08/2022 - 01/2021
6	Pyruvate Kinase Deficiency of Red Cells 01/2022 - 01/2021
5	Venous Thromboembolism 01/2021 - 01/2019
4	Epistaxis (Nosebleed) 07/2022 - 11/2020
4	Telangiectasis (Telangiectasia) 07/2022 - 11/2020
4	Hemophilia A (Haemophilia) 03/2022 - 06/2018
4	Liver Diseases (Liver Disease) 01/2022 - 01/2018
4	Fatigue 01/2022 - 01/2021
4	Hemolytic Anemia 12/2021 - 01/2020
4	COVID-19 11/2021 - 01/2020
4	Critical Illness (Critically Ill) 11/2021 - 01/2019
4	Thrombophilia 01/2021 - 01/2018
3	Aplastic Anemia (Anemia, Hypoplastic) 01/2022 - 01/2021
3	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 11/2019
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 04/2022 - 11/2019
2	Hemolysis 01/2022 - 01/2021
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2019
2	Arteriovenous Malformations (Arteriovenous Malformation) 01/2022 - 01/2020
2	Hypertension (High Blood Pressure) 01/2022 - 01/2021
2	Pulmonary Hypertension 04/2021 - 01/2020
2	Thrombocytosis (Thrombocythemia) 01/2021 - 07/2020
1	Aortic Valve Stenosis (Aortic Stenosis) 08/2022
1	Vasculitis (Vasculitides) 04/2022
1	Angiodysplasia 04/2022
1	Lung Neoplasms (Lung Cancer) 03/2022
1	Acquired amegakaryocytic thrombocytopenia 01/2022
1	Nasopharyngeal Carcinoma 01/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	Headache (Headaches) 01/2022
1	Lymphopenia (Lymphocytopenia) 01/2022
1	Nausea 01/2022
1	Fibrosis (Cirrhosis) 12/2021
1	Myocarditis (Carditis) 11/2021

Drug/Important Bio-Agent (IBA)

19	Inosine Triphosphate (ITP)IBA 10/2022 - 11/2018
15	Thrombopoietin ReceptorsIBA 03/2022 - 10/2018
10	Bevacizumab (Avastin)FDA Link 08/2022 - 01/2018
10	romiplostim FDA Link 01/2022 - 01/2018
9	AnticoagulantsIBA 10/2021 - 08/2018
7	Hemoglobins (Hemoglobin)IBA 08/2022 - 07/2020
7	avatrombopagIBA 03/2022 - 10/2018
7	eltrombopag FDA Link 01/2022 - 10/2018
6	IronIBA 08/2022 - 11/2020
4	Pyruvate KinaseIBA 01/2022 - 01/2021
4	Rituximab (Mabthera)FDA Link 01/2022 - 07/2018
4	serum P-component (CIt)IBA 12/2021 - 01/2021
3	pazopanib FDA Link 07/2022 - 01/2022
3	Angiogenesis InhibitorsIBA 07/2022 - 01/2021
3	mitapivatIBA 01/2022 - 01/2021
3	Hemostatics (Antihemorrhagics)IBA 01/2022 - 01/2020
3	fibrin fragment D (D-dimer)IBA 01/2021 - 01/2020
3	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2021 - 01/2019
2	Monoclonal AntibodiesIBA 08/2022 - 07/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2022 - 01/2021
2	Warfarin (Coumadin)FDA LinkGeneric 04/2022 - 01/2020
2	pembrolizumabIBA 01/2022 - 01/2019
2	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 01/2021
2	Ferritins (Ferritin)IBA 01/2022 - 07/2020
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2021 - 11/2019
2	Thrombopoietin (c-mpl Ligand)IBA 12/2021 - 12/2018
2	BilirubinIBA 12/2021 - 01/2021
2	Glycoproteins (Glycoprotein)IBA 11/2021 - 01/2020
2	AutoantibodiesIBA 11/2021 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2021
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 01/2019
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2019 - 08/2018
1	Thalidomide (Thalomid)FDA Link 07/2022
1	Factor VIII (Coagulation Factor VIII)IBA 03/2022
1	recombinant FVIIa (rFVIIa)FDA Link 03/2022
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 03/2022
1	prothrombin complex concentrates (PPSB)IBA 03/2022
1	trametinibIBA 01/2022
1	fostamatinibIBA 01/2022
1	abemaciclibIBA 01/2022
1	AlpelisibIBA 01/2022
1	Doxycycline (Periostat)FDA LinkGeneric 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Transferrin (beta 2 Transferrin)IBA 01/2022
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022
1	Sirolimus (Rapamycin)FDA Link 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	TOR Serine-Threonine KinasesIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2021
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 12/2021

Therapy/Procedure

25	Therapeutics 08/2022 - 01/2018
9	Drug Therapy (Chemotherapy) 03/2022 - 01/2018
3	Drug Tapering 03/2022 - 01/2021
2	Splenectomy 10/2022 - 04/2021
2	Blood Transfusion (Blood Transfusions) 04/2022 - 01/2019
2	Treatment Delay 03/2022 - 01/2021
2	Platelet Transfusion (Blood Platelet Transfusions) 03/2022 - 01/2021
2	Liver Transplantation 12/2021 - 01/2019
1	Salvage Therapy 08/2022
1	Precision Medicine 01/2022